Cogent Biosciences News - COGT

Company Name	Stock Ticker Symbol	Market	Type
Cogent Biosciences Inc	COGT	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.08	1.23%	6.61	15:05:23

Open Price	Low Price	High Price	Close Price	Prev Close
6.51	6.44	6.64		6.53

more quote information »

Recent News

Date	Time	Source	Heading
4/09/2024	09:00	GLOBE	Cogent Biosciences Presents Data Highlighting Potential..
2/26/2024	16:34	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2/26/2024	09:13	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/26/2024	08:30	EDGAR2	Form 8-K - Current report
2/26/2024	08:00	GLOBE	Cogent Biosciences Reports Recent Business Highlights and..
2/22/2024	14:30	GLOBE	Cogent Biosciences Announces Positive Part 1b Data from..
2/16/2024	18:55	EDGAR2	Form SC 13D/A - General statement of acquisition of..
2/16/2024	18:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	16:05	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/14/2024	12:51	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/14/2024	08:35	EDGAR2	Form 8-K - Current report
2/14/2024	07:00	GLOBE	Cogent Biosciences Announces Oversubscribed $225 Million..
2/09/2024	16:22	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/05/2024	09:00	GLOBE	Cogent Biosciences to Present SUMMIT Part 1b Data with..
1/25/2024	16:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/25/2024	16:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/25/2024	16:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/25/2024	16:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/09/2024	08:00	GLOBE	Cogent Biosciences Announces Planned 2024 Milestones for..
1/04/2024	16:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	08:00	GLOBE	Cogent Biosciences Announces Presentation at the 42nd Annual..
12/11/2023	08:04	EDGAR2	Form 8-K - Current report
12/11/2023	07:55	GLOBE	Cogent Biosciences Announces Positive Data from Ongoing..
12/09/2023	13:30	GLOBE	Cogent Biosciences Announces Positive Initial Data from..
12/07/2023	09:00	GLOBE	Cogent Biosciences Presents New Preclinical Data..
12/04/2023	08:00	GLOBE	Cogent Biosciences to Host Investor Webcast on December 11,..
11/29/2023	08:00	GLOBE	Cogent Biosciences Announces Poster Presentations at..
11/07/2023	07:27	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	09:18	EDGAR2	Form 8-K - Current report
11/02/2023	09:00	GLOBE	Cogent Biosciences Reports Recent Business Highlights and..
10/14/2023	12:30	GLOBE	Cogent Biosciences Presents Preclinical Data Highlighting..
10/03/2023	16:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/08/2023	16:31	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/08/2023	08:20	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	08:14	EDGAR2	Form 8-K - Current report
8/08/2023	08:00	GLOBE	Cogent Biosciences Reports Recent Business Highlights and..
7/05/2023	16:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/09/2023	16:01	GLOBE	Cogent Biosciences Announces Closing of Upsized Public..
6/07/2023	09:00	GLOBE	Cogent Biosciences Announces Participation in the Jefferies..
6/06/2023	20:25	GLOBE	Cogent Biosciences Announces Pricing of Upsized Public..
6/06/2023	16:05	GLOBE	Cogent Biosciences Announces Proposed Public Offering of..
6/03/2023	14:15	GLOBE	Cogent Biosciences Announces Positive Lead-In Data from..
5/23/2023	08:00	GLOBE	Cogent Biosciences to Host Investor Webcast to Discuss..
5/09/2023	08:00	GLOBE	Cogent Biosciences Reports Recent Business Highlights and..